BRM Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Bristol-Myers Squibb Co

Watchlist Manager

Watchlist

Price: 54.3 EUR -3.36% Market Closed

Market Cap: €110.5B

B	Bristol-Myers Squibb Co SWB:BRM	US
	Cabaletta Bio Inc NASDAQ:CABA	US
T	Thal Industries Corporation Ltd KAR:TICL	PK
N	Nano Labs Ltd NASDAQ:NA	CN
	Intermestic Inc TSE:262A	JP
W	Wintergreen Acquisition Corp NASDAQ:WTG	CN
	Waterstone Financial Inc NASDAQ:WSBF	US

Profitability Summary

Bristol-Myers Squibb Co's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

72%

Strong 3Y Average Gross Margin

74%

Declining Gross Margin

77% > 72%

Exceptional Operating Margin

35%

Sustainable 3Y Average Operating Margin

30%

Operating Margin is Increasing

24% > 35%

Healthy Net Margin

19%

Low 3Y Average Net Margin

Net Margin is Increasing

18% > 19%

Exceptional Free Cash Flow Margin

34%

Strong 3Y Average Free Cash Flow Margin

30%

Free Cash Flow Margin is Increasing

26% > 34%

Exceptional ROE

82%

Positive 3Y Average ROE

Positive 3Y Average ROIC

18%

ROIC is Increasing

12% > 49%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.